Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is de... Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0375 | 4.7456340167 | 0.7902 | 0.8578 | 0.7902 | 64801 | 0.81529722 | CS |
| 4 | -0.1021 | -10.9808560981 | 0.9298 | 0.9498 | 0.740201 | 242823 | 0.8414814 | CS |
| 12 | -0.3423 | -29.2564102564 | 1.17 | 1.2 | 0.740201 | 238869 | 0.95283971 | CS |
| 26 | -0.3423 | -29.2564102564 | 1.17 | 1.47 | 0.740201 | 230421 | 1.129607 | CS |
| 52 | -0.7323 | -46.9423076923 | 1.56 | 1.89 | 0.740201 | 226388 | 1.3531627 | CS |
| 156 | -8.2223 | -90.8541436464 | 9.05 | 9.7 | 0.6801 | 985531 | 1.82221995 | CS |
| 260 | -8.1823 | -90.8135405105 | 9.01 | 23.639 | 0.6801 | 665681 | 3.35666976 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
